Advertisement

Topics

Abiomed Incorporated Company Profile

23:25 EDT 20th September 2017 | BioPortfolio

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES. The Company's portfolio of heart support and recovery products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the catheterization lab to the surgical suite, together with interventional cardiologists and surgeons, Abiomed is dedicated to providing the most advanced medical technologies to heart patients, with the ultimate goal of heart recovery and improved quality of life. Abiomed was founded more than two decades ago and is the only company in the world with exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The Company develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. Abiomed is the global leader for products in the acute heart failure market and ships more ventricle assist devices (VADs) than any other company in the world. The Company is focused on expanding its global distribution, fueling innovation and new products to broaden the Company's product portfolio to become the world's circulatory care leader. Key Facts: Year Founded: 1981 Corporate Headquarters: Danvers, Massachusetts European Division: Aachen, Germany Number of Employees: 300+ Product and Service Offerings: Heart Recovery and Assist: BVS 5000 Bi-ventricular Support System and AB5000 Circulatory Support System In Europe, Abiomed offers the IMPELLA® RECOVER® minimally invasive Cardiovascular Support Systems under CE mark approval Heart Replacement: the AbioCor Implantable Replacement Heart, and Under Development the AbioCor II

Location

33 Cherry Hill Drive
Danvers
01923
United States of America

Contact

Phone: 978 777 5410
Fax: 978 777 8411
Email: abmd@abiomed.com


News Articles [32 Associated News Articles listed on BioPortfolio]

Abiomed: Abiomed gibt die Aufnahme des ersten Patienten in die STEMI DTU-Projektstudie bekannt

DANVERS, Mass., 5. Mai 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (http://www.abiomed.com/) (NASDAQ:ABMD), ein führender Anbieter von bahnbrechenden Herzunterstützungssystemen, hat heute die Aufnahme ...

Abiomed: Neue Studie mit Impella 2.5® Herzpumpe von Abiomed belegt nachweislich Überlebensvorteil beim prä-PCI-Einsatz der Pumpe bei Patienten mit Herzinfarkt der linken Hauptkoronararterie

DANVERS, Mass., July 3, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc (https://www.globenewswire.com/Tracker?data=zcP6Pp1wrZjuaxvGJzjaNnW122S7e70gBaoTheOmgfL3TqkF-whzZACCnCdGsrPjCL1OCRo5tMYqz6yPsJejyw==)....

Abiomed: New Study with Abiomed's Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery

DANVERS, Mass., 2017-06-30 14:17 CEST (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publica...

Abiomed enters $16.5M deal to acquire Mass. headquarters

A deal has been reached by Abiomed to pay $16.5 million for its existing corporate headquarters in Danvers, Mass., which incl -More- 

3rd-gen Impella CP heart pump unveiled by Abiomed

The third-generation Impella CP heart pump was unveiled by Abiomed at the Society for Cardiovascular and Angiography Interven -More- 

Abiomed debuts 3rd generation of its Impella heart pump

Abiomed has debuted the third generation of its Im

Abiomed posts 33 percent increase in revenue as Impella devices gain market momentum

Body: Danvers, Massachusetts-based Abiomed has posted a 33 percent increase in total sales in its fourth quarter, which exceeded market watchers’ expectations, reported The Motley Fool. Abiomed...

Abiomed: Abiomed kündigt Umsatz von 124,7 Millionen USD für das vierte Quartal des Geschäftsjahres 2017 an - 33 % höher als im Vorjahresvergleich. Der Gesamtjahresumsatz fällt mit 445,3 Millionen...

Abiomed kündigt Umsatz von 124,7 Millionen USD für das vierte Quartal des Geschäftsjahres 2017 an - 33 % höher als im Vorjahresvergleich. Der Gesamtjahresumsatz fällt mit 445,3 Millionen USD 35...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Biventricular Impella placement via complete venous access.

Impella (Abiomed, Danvers, MA) is an effective option for emergent treatment of critical refractory cardiogenic shock. However, in patients who have inadequate peripheral arterial access, Impella for ...

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

Companies [39 Associated Companies listed on BioPortfolio]

Abiomed Incorporated

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES. The Company's portfolio of heart support and recovery products and services offer healthcare profes...

Abiomed Inc.

Abiomed, Inc.

Medialink, Abiomed

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

More Information about "Abiomed Incorporated" on BioPortfolio

We have published hundreds of Abiomed Incorporated news stories on BioPortfolio along with dozens of Abiomed Incorporated Clinical Trials and PubMed Articles about Abiomed Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abiomed Incorporated Companies in our database. You can also find out about relevant Abiomed Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record